- Home
- SCNI vs NAOV Comparison
SCNI vs NAOV Comparison
Compare SCNI & NAOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCNI
- NAOV
- Stock Information
- Founded
- SCNI 2003
- NAOV 2003
- Country
- SCNI Israel
- NAOV United States
- Employees
- SCNI N/A
- NAOV N/A
- Industry
- SCNI Biotechnology: Biological Products (No Diagnostic Substances)
- NAOV Industrial Specialties
- Sector
- SCNI Health Care
- NAOV Health Care
- Exchange
- SCNI Nasdaq
- NAOV Nasdaq
- Market Cap
- SCNI 2.8M
- NAOV 3.1M
- IPO Year
- SCNI N/A
- NAOV N/A
- Fundamental
- Price
- SCNI $2.85
- NAOV $2.56
- Analyst Decision
- SCNI
- NAOV
- Analyst Count
- SCNI 0
- NAOV 0
- Target Price
- SCNI N/A
- NAOV N/A
- AVG Volume (30 Days)
- SCNI 10.1K
- NAOV 2.3M
- Earning Date
- SCNI 05-14-2025
- NAOV 05-14-2025
- Dividend Yield
- SCNI N/A
- NAOV N/A
- EPS Growth
- SCNI N/A
- NAOV N/A
- EPS
- SCNI 8.20
- NAOV N/A
- Revenue
- SCNI $452,000.00
- NAOV $2,558,000.00
- Revenue This Year
- SCNI N/A
- NAOV N/A
- Revenue Next Year
- SCNI N/A
- NAOV N/A
- P/E Ratio
- SCNI $0.34
- NAOV N/A
- Revenue Growth
- SCNI N/A
- NAOV 227.79
- 52 Week Low
- SCNI $2.23
- NAOV $1.92
- 52 Week High
- SCNI $8.92
- NAOV $13.97
- Technical
- Relative Strength Index (RSI)
- SCNI 34.84
- NAOV 36.41
- Support Level
- SCNI $2.64
- NAOV $2.90
- Resistance Level
- SCNI $2.86
- NAOV $4.69
- Average True Range (ATR)
- SCNI 0.25
- NAOV 0.66
- MACD
- SCNI -0.06
- NAOV -0.04
- Stochastic Oscillator
- SCNI 35.93
- NAOV 18.93
About SCNI Scinai Immunotherapeutics Ltd.
Scinai Immunotherapeutics Ltd is a biopharmaceutical company focused on developing, manufacturing and commercializing products for the prevention and treatment of infectious diseases and other illnesses. It has executed eight clinical trials in seven countries, around 12,400 participants in the Phase 3 trial of its vaccine candidate and has built a GMP biologics manufacturing facility for biopharmaceutical products. The company is aiming to develop a pipeline of diversified and commercially viable products and platforms beginning with a nanosized antibody (NanoAb) pipeline.
About NAOV NanoVibronix Inc.
NanoVibronix Inc manufactures noninvasive biological response-activating devices that target biofilm prevention, pain therapy, and wound healing and can be administered at home, without the assistance of medical professionals. Its primary products are UroShield; PainShield; and WoundShield. Each of its UroShield, PainShield, and WoundShield products employs a small, disposable transducer that transmits low-frequency, low-intensity ultrasound acoustic waves that seek to repair and regenerate tissue, musculoskeletal and vascular structures, and decrease biofilm formation on urinary catheters and associated urinary tract infections. The company derives revenues from selling its products directly to patients as well as through distributor agreements.